AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq (upadacitinib; 15mg once ...
Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for its ...
In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...
Bristol Myers Squibb (BMS) has announced new retrospective analyses on serologic responses and clinical outcomes with COVID-19 vaccination in participants treated with Zeposia (ozanimod) from the ...
NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...
Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...
AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square ...
Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...
This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments ...
Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms ...
Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...
At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results